Thermo Fisher Scientific Inc. (NYSE:TMO)

The financial performance indicators demonstrate a generally stable, though fluctuating, pattern over the five-year period. While net income and earnings before tax experienced declines between 2021 and 2023, they show signs of recovery in the subsequent two years. Earnings before interest and tax (EBIT) mirrored this trend, with a dip followed by improvement. Earnings before interest, tax, depreciation, and amortization (EBITDA) exhibited relative stability, with a slight decrease in 2023 before recovering.

EBITDA Trend

EBITDA remained relatively consistent, ranging between US$11.02 billion and US$11.965 billion. A slight decrease was observed in 2023, falling to US$11.02 billion, before recovering to US$11.493 billion in 2024 and remaining near that level at US$11.467 billion in 2025. This suggests a resilient operational performance despite fluctuations in other profitability metrics.

Relationship between EBT and EBITDA

The difference between Earnings Before Tax (EBT) and EBITDA narrowed between 2021 and 2023, indicating a larger proportion of EBITDA was consumed by tax expenses during that period. However, as EBT recovered in 2024 and 2025, the gap widened again, suggesting a more favorable tax position relative to overall earnings.

EBIT and EBITDA Comparison

The difference between EBIT and EBITDA remained consistent throughout the period, averaging approximately US$2.6 billion. This indicates a relatively stable depreciation and amortization expense. The parallel trends observed in both metrics suggest that changes in core operating profitability are directly reflected in both measures.

Net Income and EBITDA Correlation

Net income and EBITDA exhibited a positive correlation, though net income was more volatile. The decline in net income between 2021 and 2023 coincided with a smaller decrease in EBITDA, suggesting that factors beyond core operational profitability, such as financing costs or non-operating expenses, significantly impacted net income during those years. The subsequent recovery in net income from 2023 to 2025 was accompanied by a corresponding increase in EBITDA.

Overall, the indicators suggest a business that maintained a solid operational base, as reflected in the stable EBITDA, while experiencing some fluctuations in profitability due to factors impacting earnings below the EBITDA line. The recent recovery in net income and EBT indicates a potential improvement in overall financial health.

The Enterprise Value to EBITDA ratio exhibited a relatively stable pattern over the five-year period, with fluctuations indicating shifts in market valuation relative to operational profitability. Initial values were high, followed by a slight decrease, then an increase, and finally a return to lower levels.

Enterprise Value (EV)

Enterprise Value demonstrated a modest decline from 2021 to 2025. Beginning at US$241,765 million in 2021, it decreased to US$222,504 million by 2025. A slight dip occurred in 2022 before a small recovery in 2023, followed by more pronounced declines in 2024 and 2025.

Earnings Before Interest, Tax, Depreciation, and Amortization (EBITDA)

EBITDA remained relatively consistent throughout the period, fluctuating between US$11,020 million and US$11,965 million. A slight decrease was observed from 2021 to 2023, followed by modest increases in both 2024 and 2025, though remaining below the 2021 level.

EV/EBITDA Ratio

The EV/EBITDA ratio began at 20.21 in 2021 and increased to 21.83 in 2023, suggesting a growing premium placed on the enterprise value relative to its earnings. However, the ratio then decreased to 19.89 in 2024 and further to 19.40 in 2025. This decline indicates that the market valuation decreased relative to EBITDA, potentially reflecting changing investor sentiment or expectations regarding future growth. The ratio remained within a narrow range of approximately 19.40 to 21.83 throughout the period, indicating a generally consistent valuation approach despite the fluctuations.

The observed trends suggest a dynamic relationship between enterprise value and EBITDA. While EBITDA remained stable, changes in the EV/EBITDA ratio were primarily driven by fluctuations in Enterprise Value, indicating that external factors influencing valuation played a significant role during this period.